• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Revance Therapeutics (NQ: RVNC )

    5.840 +0.030 (+0.52%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Revance Therapeutics

    < Previous 1 2 3 4 5 6 Next >
    PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Gold Gains Over 1%; Starbucks Shares Move Higher
    Via Benzinga
    Why Is Revance Therapeutics (RVNC) Stock Up 86% Today?
    Revance Therapeutics stock is up on Monday as RVNC investors celebrate a $924 million merger agreement with Crown Laboratories. 
    Via InvestorPlace
    Crude Oil Surges 2%; B. Riley Financial Shares Plunge
    Via Benzinga
    Exposures Fossil Fuels
    Botox Innovator Revance Therapeutics Goes Private In Over $900M Deal
    Crown Laboratories will acquire Revance Therapeutics for $924 million, paying $6.66 per share — a premium of 89%. 
    Via Benzinga
    Earnings Outlook For Revance Therapeutics
    Via Benzinga
    KE Holdings, KeyCorp, Revance Therapeutics, Starbucks And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Dow Dips 150 Points; Monday.com Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    RVNC Stock Earnings: Revance Therapeutics Beats EPS, Misses Revenue for Q2 2024
    RVNC stock results show that Revance Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
    The big pharma company's top drug is losing ground, but its dividend keeps rising. 
    Via The Motley Fool
    Stocks to Buy: 3 Breakout Stars to Transform Your Portfolio
    Although breakout stocks present high risks, the underlying lack of predictability provides fuel for tremendous upside. 
    Via InvestorPlace
    The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
    Biotechs can see triple-digit returns or dramatic losses but these Piper Sandler stocks have the potential to achieve them. 
    Via InvestorPlace
    3 Underappreciated Stocks That Could 10x in 10 Years
    10x stocks are the holy grail of capital investing. So, here are three companies that have the potential to cross that line. 
    Via InvestorPlace
    Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    These Analysts Lower Their Forecasts On Revance Therapeutics After Q1 Results
    Via Benzinga
    RVNC Stock Earnings: Revance Therapeutics Beats EPS, Misses Revenue for Q1 2024
    RVNC stock results show that Revance Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
    U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    GDS Holdings, Coinbase And Other Big Stocks Moving Higher In Monday's Pre-Market Session
    U.S. stock futures were lower this morning, with the Dow futures falling by around 100 points on Monday. Shares of GDS Holdings Limited (NASDAQ: GDS) shares rose sharply in today’s pre-market trading. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its... 
    Via Benzinga
    Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
    U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
    U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Earnings Scheduled For February 28, 2024
    Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Philips Reports Q4 Results, Joins Ryanair And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    U.S. stock futures were mixed this morning, with the Dow futures falling around 50 points on Monday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Aesthetics Market Resilience: AbbVie Asserts Widely Used Botox Dominance Amidst Rising Competition
    AbbVie Inc's (NYSE: ABBV) unwavering confidence in Botox's resilience within the aesthetics market with a commanding 68% market share remains steadfast. Despite a recent FDA petition addressing... 
    Via Benzinga
    Exposures Product Safety
    Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.